Updated oncology nursing society putting evidence into practice resources

Clinical Journal of Oncology Nursing

Volumn 13, Issue 2, 2009, Pages 137-143

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAREGIVER; CLINICAL PRACTICE; CONSTIPATION; COST OF ILLNESS; EVIDENCE BASED MEDICINE; HUMAN; NEOPLASM; NURSING; ONCOLOGY NURSING; ORGANIZATION AND MANAGEMENT;

CAREGIVERS; CONSTIPATION; COST OF ILLNESS; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASMS; ONCOLOGIC NURSING; PHYSICIAN'S PRACTICE PATTERNS;

EID: 68549130653     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/09.CJON.137-143     Document Type: Review

References (41)

1. Arving, C., Sjoden, P.O., Bergh, J., Hellbom, M., Johansson, B., Glimelius, B., et al. (2007). Individual psychosocial support for breast cancer patients: A randomized study of nurse versus psychologist interventions and standard care. Cancer Nursing, 30(3), E10-E19.
2. Boyce, J.M., Pittet, D., & Healthcare Infection Control Practices Advisory Committee, Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control, & Infectious Diseases Society of America, Hand Hygiene Task Force. (2002). Guideline for hand hygiene in health-care settings: Recommendationsof the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infection Control and Hospital Epidemiology, 23(12, Suppl.), S3-S40.
3. Cohen, M., & Fried, G. (2007). Comparing relaxation training and cognitive-behavioral group therapy for women with breast cancer. Research on Social Work Practice, 17(3), 313-323.
4. Darwish, M., Kirby, M., Robertson, P., Tracewell, W., & Jiang, J.G. (2007). Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: A pilot study. Clinical Drug Investigation, 27(9), 605-611.
5. de Jong, F.A., Kehrer, D.F., Mathijssen, R.H., Creemers, G.J., de Bruijn, P., van Schaik, R.H., et al. (2006). Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: A double-blind, randomized, placebo-controlled study. Oncologist, 11(8), 944-954.
6. DeMille, D., Deming, P., Lupinacci, P., & Jacobs, L.A. (2006). The effect of the neutropenic diet in the outpatient setting: A pilot study. Oncology Nursing Forum, 33(2), 337-343.
7. Epstein, D.R., & Dirksen, S.R. (2007). Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors [Online exclusive]. Oncology Nursing Forum, 34(5), E51-E59. Retrieved March 18, 2009, from http://ons.metapress.com/content/l13681kwjk712374/
8. Espie, C.A., Fleming, L., Cassidy, J., Samuel, L., Taylor, L.M., & White, C.A. (2008). Randomized controlled clinical effectiveness trial of cognitive behavioral therapy compared with treatment as usual for persistent insomnia in patients with cancer. Journal of Clinical Oncology, 26(15), 1-9.
9. Flieger, D., Klassert, C., Hainke, S., Keller, R., Kleinschmidt, R., & Fischback, W. (2007). Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma. Oncology, 72(1-2), 10-16.
10. Freye, E., Levy, J.V., & Braun, D. (2007). Effervescent morphine results in faster relief of breakthrough pain in patients compared to immediate release morphine sulfate tablet. Pain Practice, 7(4), 324-331.
11. Gardner, A., Mattiuzzi, G., Faderl, S., Borthakur, G., Garcia-Manero, G., Pierce, S., et al. (2008). Randomized comparisonof cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia. Journal of Clinical Oncology, 26(35), 5684-5688.
12. Hagen, N.A., du Souich, P., Lapointe, B., Ong-Lam, M., Dubuc, B., Walde, D., et al. (2008). Tetrodotoxin for moderate to severe cancer pain: A randomized, double blind, parallel design multicenter study. Journal of Pain and Symptom Management, 35(4), 420-429.
13. Hagen, N.A., Fisher, K.M., Lapointe, B., du Souich, P., Chary, S., Moulin, D., et al. (2007). An open-label, multi-dose efficacy and safety study of intramuscular tetrodotoxin in patients with severe cancer-related pain. Journal of Pain and Symptom Management, 34(2), 171-182.
14. Hagen, N.A., Fisher, K., Victorino, C., & Farrar, J.T. (2007). A titration strategy is needed to manage breakthrough cancer pain effectively: Observations from data pooled from three clinical trials. Journal of Palliative Medicine, 10(1), 47-55.
15. Kehrer, D.F., Sparreboom, A., Verweij, J., de Bruijn, P., Nierop, C.A., van de Schraaf, J., et al. (2001). Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients. Clinical Cancer Research, 7(5), 1136-1141.
16. Kris, M.G., Hesketh, M.R., Somerfield, M.R., Feyer, P., Clark-Snow, R., Koeller, J., et al. (2006). American Society of Clinical Oncology guideline for antiemetics in oncology: Update 2006. Journal of Clinical Oncology, 24(18), 2932-2947.
17. Larson, E., & Nirenberg, A. (2004). Evidence-based nursing practice to prevent infection in hospitalized neutropenic patients with cancer. Oncology Nursing Forum, 31(4), 717-725.
18. Marinangeli, F., Ciccozzi, A., Aloisio, L., Colangeli, A., Paladini, A., Bajocco, C., et al. (2007). Improved cancer pain treatment using combined fentanyl-TTS and tramadol. Pain Practice, 7(4), 307-312.
19. Mercadante, S., Villari, P., Ferrera, P., Casuccio, A., Mangione, S., & Intravaia, G. (2007). Transmucosal fentanyl vs. intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain. British Journal of Cancer, 96(12), 1828-1833.
20. Mitchell, S., Beck, S., Hood, L., Moore, K., & Tanner, E. (2007). Putting Evidence Into Practice: Evidence-based interventions for fatigue during and following cancer and its treatment. Clinical Journal of Oncology Nursing, 11(1), 99-113.
21. Moody, K., Charlson, M.E., & Finlay, J. (2002). The neutropenic diet: What's the evidence? Journal of Pediatric Hematology/Oncology, 24(9), 717-721.
22. Multinational Association of Supportive Care in Cancer. (2008). Antiemetic guidelines. Retrieved June 23, 2008, from http://www.mascc.org/content/127.html
23. National Comprehensive Cancer Network. (2008a). NCCN Clinical Practice Guidelines in Oncology™: Antiemesis [v.2.2008]. Retrieved March 14, 2008, from http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
24. National Comprehensive Cancer Network. (2008b). NCCN Clinical Practice Guidelines in Oncology™: Prevention and treatment of cancer-related infections [v.1.2008]. Retrieved March 9, 2009, from http://www.nccn.org/professionals/physician_gls/PDF/infections.pdf
25. Page, M.S., Berger, A.M., & Johnson, L.B. (2006). Putting Evidence Into Practice: Evidence-based interventions for sleep-wake disturbances. Clinical Journal of Oncology Nursing, 10(6), 753-767.
26. Rao, R.D., Flynn, P.J., Sloan, J.A., Wong, G.Y., Novotny, P., Johnson, D.B., et al. (2008). Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer, 112(12), 2802-2808.
27. Rodriguez, R.F., Bravo, L.E., Castro, F., Montoya, O., Castillo, J.M., Castillo, M.P., et al. (2007). Incidence of weak opioids adverse events in the management of cancer pain: A double-blind comparative trial. Journal of Palliative Medicine, 10(1), 56-60.
28. Rosen, L.S., Abdi, E., Davis, I.D., Gutheil, J., Schnell, F.M., Zalcberg, J., et al. (2006). Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. Journal of Clinical Oncology, 24(433), 5194-5200.
29. Siegel, J.D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007a). 2007 Guideline for isolation precautions: Preventing transmission of infectious agents in health care settings. American Journal of Infection Control, 35(10, Suppl. 2), S65-S164.
30. Siegel, J.D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007b). Management of multidrug-resistant organisms in health care settings, 2006. American Journal of Infection Control, 35(10, Suppl. 2), S165-S193.
31. Slatkin, N.E., Xie, F., Messina, J., & Segal, T.J. (2007). Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain. Journal of Supportive Oncology, 5(7), 327-334.
32. Smith, L.H., & Besser, S.G. (2000). Dietary restrictions for patients with neutropenia: A survey of institutional practices. Oncology Nursing Forum, 27(3), 515-520.
33. Somerville, E.T. (1986). Special diets for neutropenic patients: Do they make a difference? Seminars in Oncology Nursing, 2(1), 55-58.
34. Sorensen, J.B., Skovsgaard, T., Bork, E., Damstrup, L., & Ingeberg, S. (2008). Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer, 112(7), 1600-1606.
35. Swarm, R., Anghelescu, D.L., Benedetti, C., Boston, B., Cleeland, C., Coyle, N., et al. (2007). Adult cancer pain. Journal of the National Comprehensive Cancer Network, 5(8), 726-751.
36. Topkan, E., & Karaoglu, A. (2006). Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma. Oncology, 71(5-6), 354-360.
37. van Tiel, F., Harbers, M.M., Terporten, P.H., van Boxtel, R.T., Kessels, A.G., Voss, G.B., et al. (2007). Normal hospital and low-bacterial diet in patients with cytopenia after intensive chemotherapy for hematological malignancy: A study of safety. Annals of Oncology, 18(6), 1080-1084.
38. Vilela, L.D., Nicolau, B., Mahmud, S., Edgar, L., Hier, M., Black, M., et al. (2006). Comparison of psychosocial outcomes in head and neck cancer patients receiving a coping strategies intervention and control subjects receiving no intervention. Journal of Otolaryngology, 35(2), 88-96.
39. Wang, W., Lin, J., Lin, T., Chen, W., Jiang, J., Wang, H., et al. (2007). Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist, 12(3), 312-319.
40. Wilson, B.J. (2002). Dietary recommendations for neutropenic patients. Seminars in Oncology Nursing, 18(1), 44-49.
41. Zanetti, G., Marchiori, E., Gasparetto, T.D., Escuissato, D.L., & Souza, A.S. (2007). Lipoid pneumonia in children following aspiration of mineral oil used in the treatment of constipation: High resolution CT findings in 17 patients. Pediatric Radiology, 37(11), 1135-1139.